跳至主要内容
临床试验/NCT03473834
NCT03473834已完成不适用

Responses of Modified Exercise Programme on Improvement of Axial Rigidity and Turning Dysfunction in Individuals With Parkinson's Disease

Mahidol University1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2018年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
1
主要终点
Fall Efficacy Score (FES-I)

研究概览

简要总结

A feasibility study using measures of turning function derived from Inertial Measurement Unit sensory before, and after, a modified exercise programme approach.

详细描述

Participants will be patients diagnosed as having idiopathic PD by a neurologist. Patients will be recruited from the Movement Disorder Clinic, Division of Neurology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand. Participants will be classified into two groups; the treatment and the control groups. All participants will be asked to sign an informed consent form approved by the ethical committee of Mahidol University Institutional Review Board, Mahidol University, Thailand. Only patients with PD who meet the inclusion and exclusion criteria will be invited to participate in the study. All participants will be assessed for daily activity and motor skill using the Unified Parkinson's Disease Rating Scale (UPDRS). At pre- and post- assessments, eye movement and turning characteristics will be assessed using Inertial Measurement Unit sensors and Electroocculography (EOG). The treatment group will receive a rehabilitation program by the physiotherapist. The rehabilitation sessions will take place at the Faculty of Physical Therapy, Mahidol University, Thailand. The control group will receive a diary for recording their daily activities during the duration of participation in this study. In addition, the researcher will phone participants once per week to remind then to maintain their diary records.

Data Processing & Analysis: this study will be used the outcome measures and processing data in MATLAB.

Statistical analysis

Kolmogorov Smirnov Goodness of Fit Test will be used to test the data distribution. If the data are normal or non-normal distribution, data comparisons will be tested as the following;

  • Normal distribution: Mixed model ANOVA will be used to compare outcome measures between pre- and post- and between the treatment and the control groups
  • Non-normal distribution: The Mann-Whitney U test will be used to compare outcome measures between the treatment and control groups. Wilcoxon Signed-Rank test will be used to compare outcome measures between pre- and post- assessments within group.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Presenting clinical diagnosis of Parkinson's disease stage 2 to 3 by modified Hoehn and Yahr Scale assessment
  • •Age ranges from 50-75 years
  • •Having stable PD medication usage at least 1 month
  • •No wearing-off phenomenon
  • •Able to walk independently without using any assistive device
  • •Able to follow commands and instruction

排除标准

  • •Presenting clinical diagnosis of dementia
  • •Having other neurological, cardiopulmonary, or lower extremities musculoskeletal problems which influence the test performance.
  • •Having high blood pressure [more than 140/90 mmHg]
  • •Having hemodialysis
  • •Having visual problems which cannot be adjusted by the lens or glasses

研究组 & 干预措施

Modified exercise programme

Experimental

Modified exercise program is the intervention for the exercise group that they will be received this programm over 1 month.

干预措施: Modified exercise programme (Other)

Modified exercise programme

Experimental

Modified exercise program is the intervention for the exercise group that they will be received this programm over 1 month.

干预措施: Medication (Behavioral)

Parkinson's disease Medication

Active Comparator

Medication is the standard treatment for individuals with Parkinson's disease. Therefore, the control group will be received the medication only.

干预措施: Medication (Behavioral)

结局指标

主要结局

Fall Efficacy Score (FES-I)

时间窗: 5 months

FES-I is a questionnaire to assess fear of falling (31). There is 16-item which developed by the Prevention of Falls Network Europe group (ProFaNE) to augment content covered by the original 10-item Fall Efficacy Score (FES). Participants will be asked to rate 16 items of questionnaire on a four-point Likert scale which is their concerns about the possibility of falling when performing 16 activities. A total score is 64 score, a higher score indicates a greater fear of falling.

Reorientation onset of body segment

时间窗: 5 months

Previous research has shown that turning in healthy adults is a whole-body coordinated process characterized by a top-down sequence of body segments reorientation starting with the eyes and head followed by the trunk and ending with the feet (Hollands, Ziavra, \& Bronstein, 2004; Mak et al., 2008). However, Lohnes and Earhart (2011) provided evidence that impaired turn performance in PD patients could be partially explained by eye movement deficits, affecting eye, head and body coordination (Lohnes \& Earhart, 2011).

Functional Reach test

时间窗: 5 months

To assess clinical balance

Body Mass Index (BMI)

时间窗: 5 months

weight and height will be combined to report BMI in kg/m\^2

Unified Parkinson's Disease Rating Scale (UPDRS)

时间窗: 5 months

The Unified Parkinson's Disease Rating Scale, abbreviated UPDRS is a scoring system widely used for the clinical evaluation of Parkinson's disease (PD). Its 42 items are evaluated by interview and clinical observation. Clinicians and researchers alike use the UPDRS and the motor section in particular to follow the progression of a person's Parkinson's disease. Scientific researchers use it to measure benefits from a given therapy in a more unified and accepted rating system. Neurologists also use it in clinical practice to follow the progression of their patients' symptoms in a more objective manner. A total of 199 points are possible (199 represents the worst disability and 0 no disability).

次要结局

  • Borge Scale(5 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验